China Insider Interview | Dr. Steven Quay, Senior Fellow Hudson Institute

Miles sits down with Dr. Steven Quay, Senior Fellow at Hudson Institute as well as the Founder and CEO of Atossa Therapeutics, Inc., to discuss the evolving landscape of emerging technology and AI-enabled biological warfare operations. With the increased potential for integrated dual-use technology in hybridized warfare tactics, the international community must develop counterstrategies to prevent the proliferation of biothreats and biological weapons, and adequately prepare for future military and public health crises. The conversation pulls from the lessons learned during the COVID-19 pandemic, provides an assessment of the current capabilities of dual-use biothreats within China’s military doctrine, and critiques the current lack of global governance infrastructure to regulate AI-enabled biotechnologies. China Insider is a weekly podcast project from Hudson Institute’s China Center, hosted by China Center Director and Senior Fellow, Dr. Miles Yu, who provides weekly news that mainstream American outlets often miss, as well as in-depth commentary and analysis on the China challenge and the free world’s future.